The "cell of origin" of the second most common lung cancer and the way that it becomes dominant in the lung have been ...

Encompass Health tapped Patrick Tuer to serve as its first COO. He has held various leadership positions, including group ...

There is no standard of care for fibrolamellar liver cancer, no targeted therapies. But that may be changing, thanks to recent findings by rare cancer researcher Dr. Taran Gujral, head of Fred Hutch's ...

Mammary gland fibroblasts are highly plastic and transition through distinct states during development and disease. A new ...